Kissel JT - Search Results

1

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.

Thornton CA, Moxley RT 3rd, Eichinger K, Heatwole C, Mignon L, Arnold WD, Ashizawa T, Day JW, Dent G, Tanner MK, Duong T, Greene EP, Herbelin L, Johnson NE, King W, Kissel JT, Leung DG, Lott DJ, Norris DA, Pucillo EM, Schell W, Statland JM, Stinson N, Subramony SH, Xia S, Bishop KM, Bennett CF. Thornton CA, et al. Among authors: kissel jt. Lancet Neurol. 2023 Mar;22(3):218-228. doi: 10.1016/S1474-4422(23)00001-7. Lancet Neurol. 2023. PMID: 36804094 Clinical Trial.

2

Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group.

Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, Burghes AH, Mendell JR. Burrow KL, et al. Among authors: kissel jt. Neurology. 1991 May;41(5):661-6. doi: 10.1212/wnl.41.5.661. Neurology. 1991. PMID: 1781820 Clinical Trial.

3

Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group.

Kissel JT, Burrow KL, Rammohan KW, Mendell JR. Kissel JT, et al. Neurology. 1991 May;41(5):667-72. doi: 10.1212/wnl.41.5.667. Neurology. 1991. PMID: 2027481 Clinical Trial.

4

Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy.

Huber SJ, Kissel JT, Shuttleworth EC, Chakeres DW, Clapp LE, Brogan MA. Huber SJ, et al. Among authors: kissel jt. Arch Neurol. 1989 May;46(5):536-40. doi: 10.1001/archneur.1989.00520410070026. Arch Neurol. 1989. PMID: 2636847

5

Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, et al. Mendell JR, et al. Among authors: kissel jt. N Engl J Med. 1995 Sep 28;333(13):832-8. doi: 10.1056/NEJM199509283331303. N Engl J Med. 1995. PMID: 7651473 Free article. Clinical Trial.

6

A molecular protocol for diagnosing myotonic dystrophy.

Guida M, Marger RS, Papp AC, Snyder PJ, Sedra MS, Kissel JT, Mendell JR, Prior TW. Guida M, et al. Among authors: kissel jt. Clin Chem. 1995 Jan;41(1):69-72. Clin Chem. 1995. PMID: 7813083

7

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.

Kissel JT, Lynn DJ, Rammohan KW, Klein JP, Griggs RC, Moxley RT 3rd, Cwik VA, Brooke MH, Mendell JR. Kissel JT, et al. Neurology. 1993 Mar;43(3 Pt 1):532-6. doi: 10.1212/wnl.43.3_part_1.532. Neurology. 1993. PMID: 8450996 Clinical Trial.

8

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D. Tawil R, et al. Ann Neurol. 1996 Jun;39(6):744-8. doi: 10.1002/ana.410390610. Ann Neurol. 1996. PMID: 8651646

9

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC. Tawil R, et al. Neurology. 1997 Jan;48(1):46-9. doi: 10.1212/wnl.48.1.46. Neurology. 1997. PMID: 9008492

10

Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R. Kissel JT, et al. Neurology. 1998 May;50(5):1402-6. doi: 10.1212/wnl.50.5.1402. Neurology. 1998. PMID: 9595995 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page